- Report
- March 2025
- 50 Pages
Global
From €2519EUR$2,650USD£2,116GBP
- Report
- March 2025
- 50 Pages
Global
From €2519EUR$2,650USD£2,116GBP
- Report
- September 2024
- 28 Pages
United Kingdom
From €995EUR$1,121USD£865GBP
- Report
- August 2024
- 200 Pages
China
From €3803EUR$4,000USD£3,195GBP
- Report
- August 2024
- 100 Pages
China
From €1711EUR$1,800USD£1,438GBP
- Report
- November 2021
- 600 Pages
Global
From €3803EUR$4,000USD£3,195GBP
- Report
- January 2023
- 359 Pages
Global
From €3394EUR$3,570USD£2,851GBP
- Report
- August 2022
- 324 Pages
Global
From €3651EUR$3,840USD£3,067GBP
- Report
- May 2022
- 213 Pages
Global
From €3529EUR$3,712USD£2,965GBP
Codeine is an opioid analgesic drug used to treat mild to moderate pain. It is derived from the opium poppy and is available in both prescription and over-the-counter forms. Codeine is often used in combination with other analgesics, such as acetaminophen or ibuprofen, to provide more effective pain relief. It is also used to treat coughs and diarrhea. Codeine is generally considered to be less potent than other opioids, such as morphine, and is therefore less likely to cause addiction or overdose.
The codeine market is a subset of the larger analgesics market, which includes both prescription and over-the-counter drugs. The analgesics market is highly competitive, with a wide range of products available to consumers. The codeine market is also highly competitive, with a variety of products available from different manufacturers.
Some of the companies in the codeine market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck, and Novartis. Show Less Read more